Table 1.
Demographic information and lab test results for patient 1, patient 2, patient 3
| Patient 1 | Patient 2 | Patient 3 | |
|---|---|---|---|
| Age/Gender | 18/F | 18/M | 21/M |
| History of vaping | + | + | + |
| Fever | + | + | – |
| Rapid respiratory viral panel* | N/A | – | – |
| Influenza A/B | – | – | N/A |
| HIV | – | – | N/A |
| Mycoplasma pneumoniae | – | – | N/A |
| Chlamydia psittaci, chlamydia pneumoniae | – | – | N/A |
| Streptococcus pneumoniae | N/A | – | – |
| Legionella | – | – | – |
| Shigella | N/A | – | N/A |
| Giardia | N/A | – | N/A |
| Cyclospora, ova/parasites | N/A | – | N/A |
| Clostridium difficile | – | – | N/A |
| Norovirus | N/A | – | N/A |
| IgE | WNL | + | WNL |
| ANA | – | – | N/A |
| p-ANCA/c-ANCA | – | – | – |
| ABG showing low oxygen saturation | N/A | N/A | + |
| Imaging showing bilateral opacities | + | + | + |
| Urine toxicology report | Positive for cannabinoids | Positive for cannabinoids and opiates | Positive for cannabinoids and benzodiazepines |
| Length of stay inpatient | 6 days | 9 days | 8 days |
WNL indicates within normal limits
N/A indicates not applicable (not tested)
*Rapid respiratory viral panel tested for: adenovirus; coronavirus (HKU1, NL63, 229E, OC43); human metapneumovirus (hMPV); human enterovirus/rhinovirus (Entero/RV); influenza A; influenza A/H1; influenza A/H3; influenza A/H1–2009; influenza B; parainfluenza viruses 1, 2, 3, 4; respiratory syncytial virus; Mycoplasma pneumoniae; and Chlamydophilia pneumoniae